Trial Profile
A trial of tolvaptan for the treatment of heart failure patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 25 Feb 2016 New trial record